NDC11 87564001010
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 87564-0010-10 | 87564-0010 |
| 87564-010-10 | 87564-010 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TERBINAFINE | TERBINAFINE HYDROCHLORIDE TABLET | Amerisyn LLC | 584d1fae-0120-49a0-e063-6394a90a36fc | 2026-08-05 | Warnings, Adverse reactions | 87564-010-10 87564-010 87564001010 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.